Emile Voest
25-04-2023
Just one WGS test is enough to reveal everything you need to know to provide a patient with metastatic cancer with targeted treatment, be it a registered therapy or part of a research trial.
Back to newsMore news
Single WGS analysis of metastases is sufficient in most cases
26-10-2021
DNA analysis of the tumor is of crucial importance to determine treatment options for patients with metastasized lung cancer. But …
Measuring the effects of radiotherapy on cancer may open up avenues for treatment
21-05-2021
Radiotherapy works by damaging the DNA of cancer cells. It’s an effective strategy overall, but many cancers have subsets of …
Patients can benefit from whole genome sequencing for immunotherapy
01-10-2020
Immunotherapy is an effective treatment for many people with cancer. The number of abnormalities in the DNA of the tumor in …
WGS is a helpful addition to our toolbox, alongside the classic HE, IHC and the (broad) NGS panels and should ideally be available in every regional oncology network
Head of the Pathology department, Leiden University Medical Center (LUMC)